Identification and functional assessment of BCRP polymorphisms in a Korean population

被引:45
作者
Lee, Sang Seop
Jeong, Hye-Eun
Yi, Joo-Mi
Jung, Hyun-Ju
Jang, Jae-Eun
Kim, Eun-Young
Lee, Su-Jun
Shin, Jae-Gook
机构
[1] Inje Univ, Coll Med, Busan Paik Hosp, Dept Pharmacol, Pusan, South Korea
[2] Inje Univ, Coll Med, Busan Paik Hosp, Pharmacogenom Res Ctr, Pusan, South Korea
[3] Inje Univ, Coll Med, Busan Paik Hosp, Dept Clin Pharmacol, Pusan, South Korea
关键词
D O I
10.1124/dmd.106.012302
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The breast cancer resistance protein ( BCRP) is a member of the ATP-binding cassette transporters. The aim of the present study was to identify genetic variants of BCRP in Koreans and to assess the functional consequences of BCRP polymorphisms. Twenty single nucleotide polymorphisms ( SNP), including four nonsynonymous SNP, were identified by DNA sequencing of the BCRP gene in 92 Korean subjects. BCRP V12M, Q141K, P269S, and Q126Stop were detected at frequencies of 23, 28, 0.2, and 1.9%, respectively. These four coding variants were also screened in Chinese and Vietnamese subjects; the allelic frequencies among the three populations were compared; and predictions were made as to the potential frequency of each variant. In vitro functional analyses of the P269S protein and the promoter SNP - 19031C > T ( mutated in the hypoxia-inducible factor-1 alpha binding site) were performed and compared with those of the wild type. P269S exhibited a 35 to 40% decrease in vesicular uptake of [H-3] estrone-3-sulfate and [H-3] methotrexate compared with the wild type. The promoter SNP - 19031C > T did not affect BCRP promoter activity in either the presence or absence of chemical-induced hypoxic stress. Our results suggest that the P269S variant could be a functionally altered variant. Genotyping of this variant in clinical studies is needed to address its phenotypic role. Genetic polymorphisms of BCRP were found to be very common in Koreans, as well as in other ethnic groups. Comparative analyses among three Asian populations revealed different frequencies for the four functional BCRP variants.
引用
收藏
页码:623 / 632
页数:10
相关论文
共 35 条
[11]   Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan [J].
Jonker, JW ;
Smit, JW ;
Brinkhuis, RF ;
Maliepaard, M ;
Beijnen, JH ;
Schellens, JHM ;
Schinkel, AH .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (20) :1651-1656
[12]  
Kim M, 2002, CLIN CANCER RES, V8, P22
[13]   Functional assessment of ABCG2 (BCRP) gene polymorphisms to protein expression in human placenta [J].
Kobayashi, D ;
Ieiri, I ;
Hirota, T ;
Takane, H ;
Maegawa, S ;
Kigawa, J ;
Suzuki, H ;
Nanba, E ;
Oshimura, M ;
Terakawa, N ;
Otsubo, K ;
Mine, K ;
Sugiyama, Y .
DRUG METABOLISM AND DISPOSITION, 2005, 33 (01) :94-101
[14]   Functional analysis of SNPs variants of BCRP/ABCG2 [J].
Kondo, C ;
Suzuki, H ;
Itoda, M ;
Ozawa, S ;
Sawada, J ;
Kobayashi, D ;
Ieiri, I ;
Mine, K ;
Ohtsubo, K ;
Sugiyama, Y .
PHARMACEUTICAL RESEARCH, 2004, 21 (10) :1895-1903
[15]   Association of the BCRP C421A polymorphism with nonpapillary renal cell carcinoma [J].
Korenaga, Y ;
Naito, K ;
Okayama, N ;
Hirata, H ;
Suehiro, Y ;
Hamanaka, Y ;
Matsuyama, H ;
Hinoda, Y .
INTERNATIONAL JOURNAL OF CANCER, 2005, 117 (03) :431-434
[16]   The stem cell marker Bcrp/ABCG2 enhances hypoxic cell survival through interactions with heme [J].
Krishnamurthy, P ;
Ross, DD ;
Nakanishi, T ;
Bailey-Dell, K ;
Zhou, S ;
Mercer, KE ;
Sarkadi, B ;
Sorrentino, BP ;
Schuetz, JD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (23) :24218-24225
[17]   Identification and functional characterization of novel CYP2J2 variants: G312R variant causes loss of enzyme catalytic activity [J].
Lee, SS ;
Jeong, HE ;
Liu, KH ;
Ryu, JY ;
Moon, T ;
Yoon, CN ;
Oh, SJ ;
Yun, CH ;
Shin, JG .
PHARMACOGENETICS AND GENOMICS, 2005, 15 (02) :105-113
[18]   From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance [J].
Litman, T ;
Druley, TE ;
Stein, WD ;
Bates, SE .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2001, 58 (07) :931-959
[19]   Use of peptide antibodies to probe for the mitoxantrone resistance-associated protein MXR/BCRP/ABCP/ABCG2 [J].
Litman, T ;
Jensen, U ;
Hansen, A ;
Covitz, KM ;
Zhan, ZR ;
Fetsch, P ;
Abati, A ;
Hansen, PR ;
Horn, T ;
Skovsgaard, T ;
Bates, SE .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2002, 1565 (01) :6-16
[20]  
Litman T, 2000, J CELL SCI, V113, P2011